Hayek Kallen Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.28M | Sell |
32,910
-27
| -0.1% | -$5.81K | 2.51% | 11 |
|
|
2026
Q1 | $7.16M | Buy |
+32,937
| New | +$7.31M | 2.33% | 11 |
|
|
2025
Q4 | – | Sell |
-33,486
| Closed | -$7.75M | – | 95 |
|
|
2025
Q3 | $7.75M | Sell |
33,486
-149
| -0.4% | -$30.3K | 2.45% | 11 |
|
|
2025
Q2 | $6.24M | Buy |
33,635
+722
| +2% | +$134K | 2.12% | 12 |
|
|
2025
Q1 | $6.9M | Sell |
32,913
-544
| -2% | -$106K | 2.54% | 9 |
|
|
2024
Q4 | $5.95M | Buy |
33,457
+369
| +1% | +$67.8K | 2.16% | 12 |
|
|
2024
Q3 | $6.53M | Sell |
33,088
-28
| -0.1% | -$5.23K | 2.32% | 11 |
|
|
2024
Q2 | $5.68M | Buy |
33,116
+149
| +0.5% | +$24.7K | 2.12% | 12 |
|
|
2024
Q1 | $6M | Buy |
32,967
+115
| +0.4% | +$19.8K | 2.3% | 11 |
|
|
2023
Q4 | $5.09M | Buy |
32,852
+292
| +0.9% | +$42.6K | 2.13% | 12 |
|
|
2023
Q3 | $4.85M | Sell |
32,560
-157
| -0.5% | -$23K | 2.17% | 13 |
|
|
2023
Q2 | $4.41M | Buy |
32,717
+499
| +2% | +$73.2K | 1.88% | 14 |
|
|
2023
Q1 | $5.13M | Buy |
32,218
+150
| +0.5% | +$22.9K | 2.32% | 12 |
|
|
2022
Q4 | $5.18M | Sell |
32,068
-570
| -2% | -$87.4K | 2.39% | 11 |
|
|
2022
Q3 | $4.38M | Buy |
32,638
+515
| +2% | +$73.9K | 2.06% | 14 |
|
|
2022
Q2 | $4.92M | Sell |
32,123
-554
| -2% | -$84.7K | 2.14% | 15 |
|
|
2022
Q1 | $5.3M | Sell |
32,677
-253
| -0.8% | -$36.8K | 1.96% | 17 |
|
|
2021
Q4 | $4.46M | Buy |
32,930
+468
| +1% | +$55.3K | 1.59% | 23 |
|
|
2021
Q3 | $3.5M | Buy |
32,462
+286
| +0.9% | +$32.7K | 1.6% | 25 |
|
|
2021
Q2 | $3.62M | Buy |
32,176
+205
| +0.6% | +$23.1K | 1.52% | 26 |
|
|
2021
Q1 | $3.46M | Buy |
31,971
+161
| +0.5% | +$17.2K | 1.56% | 26 |
|
|
2020
Q4 | $3.41M | Buy |
31,810
+671
| +2% | +$64.5K | 1.65% | 23 |
|
|
2020
Q3 | $2.73M | Buy |
31,139
+611
| +2% | +$57.5K | 1.52% | 25 |
|
|
2020
Q2 | $3M | Sell |
30,528
-269
| -0.9% | -$23.7K | 1.7% | 22 |
|
|
2020
Q1 | $2.35M | Buy |
30,797
+941
| +3% | +$80.2K | 1.57% | 26 |
|
|
2019
Q4 | $2.64M | Sell |
29,856
-169
| -0.6% | -$14K | 1.53% | 27 |
|
|
2019
Q3 | $2.27M | Sell |
30,025
-353
| -1% | -$24.2K | 1.42% | 28 |
|
|
2019
Q2 | $2.21M | Sell |
30,378
-1,174
| -4% | -$92.3K | 1.4% | 29 |
|
|
2019
Q1 | $2.54M | Sell |
31,552
-1,145
| -4% | -$93.7K | 1.65% | 27 |
|
|
2018
Q4 | $3.01M | Sell |
32,697
-1,390
| -4% | -$122K | 2.16% | 18 |
|
|
2018
Q3 | $3.22M | Sell |
34,087
-541
| -2% | -$51.3K | 2.06% | 19 |
|
|
2018
Q2 | $3.21M | Sell |
34,628
-542
| -2% | -$52.9K | 2.22% | 17 |
|
|
2018
Q1 | $3.33M | Sell |
35,170
-2,674
| -7% | -$294K | 2.31% | 17 |
|
|
2017
Q4 | $3.66M | Sell |
37,844
-2,253
| -6% | -$212K | 2.4% | 17 |
|
|
2017
Q3 | $3.56M | Sell |
40,097
-1,640
| -4% | -$125K | 2.44% | 16 |
|
|
2017
Q2 | $3.03M | Sell |
41,737
-275
| -0.7% | -$18.5K | 2.04% | 25 |
|
|
2017
Q1 | $2.74M | Buy |
42,012
+16
| +0% | +$1.01K | 1.9% | 26 |
|
|
2016
Q4 | $2.63M | Sell |
41,996
-540
| -1% | -$33K | 1.92% | 27 |
|
|
2016
Q3 | $2.68M | Buy |
42,536
+209
| +0.5% | +$13.5K | 1.91% | 28 |
|
|
2016
Q2 | $2.62M | Sell |
42,327
-390
| -0.9% | -$23.8K | 1.88% | 28 |
|
|
2016
Q1 | $2.44M | Buy |
42,717
+236
| +0.6% | +$13.2K | 1.81% | 29 |
|
|
2015
Q4 | $2.52M | Buy |
42,481
+251
| +0.6% | +$14.5K | 1.93% | 26 |
|
|
2015
Q3 | $2.3M | Buy |
42,230
+10,357
| +32% | +$674K | 1.79% | 29 |
|
|
2015
Q2 | $2.14M | Buy |
31,873
+16,176
| +103% | +$1.06M | 1.6% | 30 |
|
|
2015
Q1 | $919K | Buy |
15,697
+1,350
| +9% | +$81.6K | 0.68% | 39 |
|
|
2014
Q4 | $939K | Sell |
14,347
-150
| -1% | -$9.46K | 0.69% | 39 |
|
|
2014
Q3 | $837K | Sell |
14,497
-25
| -0.2% | -$1.39K | 0.64% | 39 |
|
|
2014
Q2 | $820K | Buy |
14,522
+104
| +0.7% | +$5.46K | 0.62% | 40 |
|
|
2014
Q1 | $741K | Sell |
14,418
-121
| -0.8% | -$6.12K | 0.59% | 42 |
|
|
2013
Q4 | $768K | Buy |
14,539
+155
| +1% | +$7.62K | 0.6% | 42 |
|
|
2013
Q3 | $643K | Sell |
14,384
-495
| -3% | -$21.9K | 0.53% | 44 |
|
|
2013
Q2 | $615K | Buy |
+14,879
| New | +$651K | 0.52% | 43 |
|
Other funds holding ABBV
Hayek Kallen Investment Management's ABBV Position: Q2 2026 in Review
Hayek Kallen Investment Management reduced its AbbVie (ABBV) stake by 0.08% in Q2 2026, selling an estimated $5.81K and leaving 32,910 shares worth $8.28M. The position accounts for 2.51% of the portfolio, ranked #11.
Hayek Kallen Investment Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Hayek Kallen Investment Management held 32,910 shares of AbbVie worth $8.28M as of Q2 2026.
- Hayek Kallen Investment Management sold 27 AbbVie shares in Q2 2026, an estimated $5.81K.
- AbbVie made up 2.51% of Hayek Kallen Investment Management's portfolio in Q2 2026, its #11 holding.
- Hayek Kallen Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Hayek Kallen Investment Management's 13F filing for Q2 2026, filed 17 Aug 2026.